This means that they will usually have a shorter life expectancy than someone with a label of GOLD grade 1, group A. Learn more about the stages of COPD. BODE provides an overall picture of how ...

GSK has been studying Nucala in COPD for some time ... and in the interim has had its label extended to include chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Current off-label treatments and antifibrotics are often ineffective against chronic cough, leaving a substantial unmet need. The results from this study will help us determine the optimal doses ...